ANTITUMORZUSAMMENSETZUNG
European patent · EP3822355 · In force
Register entry
- Publication number
- EP3822355
- Application number
- EP19833073
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 10, 2019
- Published
- May 19, 2021
- Granted
- May 20, 2026
- Protection ends at the latest
- Jul 9, 2039
- Next annual fee due
- Jul 31, 2027
- IPC classes
- C12N 15/86 (2006.01)C12N 15/113 (2010.01)C07K 14/54 (2006.01)A61K 38/00 (2006.01)A61K 48/00 (2006.01)A61P 35/00 (2006.01)C07K 14/71 (2006.01)A61K 35/761 (2015.01)
- Priority
- KR 20180079752 10.07.2018
- PCT application
- PCT/KR2019/008514 10.07.2019
- PCT publication
- WO2020/013617 16.01.2020
- Filing language
- Korean
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
- Jul 1, 2026
Agent entered
- Representative
- VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 01.07.2026
- May 20, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 20.05.2026
Parties
Inventor
YUN, Chae Ok
Seoul 06583, KR
OH, Eon Ju
Seoul 04761, KR
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.